New York, NY -- (SBWIRE) -- 01/17/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Vonage Holdings Corp (NYSE:VG), Unilife Corp (NASDAQ:UNIS), Peregrine Pharmaceuticals (NASDAQ:PPHM), Companhia Siderurgica Nacional (ADR) (NYSE:SID)
Vonage Holdings Corp (NYSE:VG) showed a volume of 2.54 million shares by the end of last trade whereas the average volume of the stock remained 1.30 million shares. The stock opened the session at $3.80 but then moved to $3.90. At that price, the stock showed a positive performance of 2.90%. Vonage Holdings Corp. (Vonage) is a provider of communications services connecting people through broadband devices worldwide. The Company’s network include session initiation protocol (SIP) based voice over Internet protocol (VoIP), network on the Internet.
Will VG Continue To Move Higher? Find Out Here
Unilife Corp (NASDAQ:UNIS) opened the session at $4.62 and closed the session at $4.85. The stock showed a positive performance of 4.75% in previous trading session. Traded with volume of 2.45 million shares in the prior session and the average volume of the stock remained 1.74 million shares. Unilife Corporation (Unilife) is a developer, manufacturer and supplier of injectable drugs delivery systems. The Company manufactures and supplies its devices to pharmaceutical companies in a format where they can be filled and packaged with an injectable therapy prior to its shipment to the end-user.
For How Long UNIS will fight for Profitability? Read This Trend Analysis report
Peregrine Pharmaceuticals (NASDAQ:PPHM) opened the session at $1.74 and closed the session at $1.70. The stock showed a negative performance of -1.16% in previous trading session. Traded with volume of 2.40 million shares in the prior session and the average volume of the stock remained 3.01 million shares. The beta of the stock remained 1.22. Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer. The Company's pipeline of investigational monoclonal antibodies is based on two technology platforms, including PS-targeting antibodies and DNA/histone-targeting antibodies.
Why Should Investors Buy PPHM After the Recent Fall? Just Go Here and Find Out
Companhia Siderurgica Nacional (ADR) (NYSE:SID) the stock advanced 0.17% and finished the session at $5.83. Traded with volume of 2.44 million shares in the prior session and the average volume of the stock remained 4.87 million shares. The beta of the stock remained 1.61. Companhia Siderurgica Nacional (CSN) is a Brazil-based company primarily engaged in the steel industry. The Company divides its business into five segments: Steel sector, which is involved in the production, distribution and marketing of flat steel, galvanized steel and metal packaging; Mining sector,
Will SID Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)